89 related articles for article (PubMed ID: 1285361)
21. Preoperative C-reactive protein as a prognostic and therapeutic marker for colorectal cancer.
Koike Y; Miki C; Okugawa Y; Yokoe T; Toiyama Y; Tanaka K; Inoue Y; Kusunoki M
J Surg Oncol; 2008 Dec; 98(7):540-4. PubMed ID: 18937231
[TBL] [Abstract][Full Text] [Related]
22. [CEA, CA 19.9 and CA 195 in patients with colorectal carcinoma. ROC analysis].
Vallejo J; Torres-Avisbal M; Contreras P; Rodríguez-Liñán M; Rebollo A; González F; Benítez A; Infante J; Mateo A
Rev Esp Med Nucl; 1999 Aug; 18(4):281-6. PubMed ID: 10481111
[TBL] [Abstract][Full Text] [Related]
23. Soluble intercellular adhesion molecule-1 in colorectal cancer and its relationship to acute phase proteins.
Reinhardt KM; Steiner M; Zillig D; Nagel HR; Blann AD; Brinckmann W
Neoplasma; 1996; 43(2):65-7. PubMed ID: 8843964
[TBL] [Abstract][Full Text] [Related]
24. Increased serum level of sialyl Lewis(x) antigen in blood from the tumor drainage vein in patients with non-polypoid growth type of colorectal cancer.
Nakagoe T; Sawai T; Tsuji T; Jibiki M; Ohbatake M; Nanashima A; Yamaguchi H; Kurosaki N; Yasutake T; Ayabe H; Arisawa K
J Exp Clin Cancer Res; 2001 Mar; 20(1):85-90. PubMed ID: 11370835
[TBL] [Abstract][Full Text] [Related]
25. Serum macrophage-colony stimulating factor levels in colorectal cancer patients correlate with lymph node metastasis and poor prognosis.
Mroczko B; Groblewska M; Wereszczyńska-Siemiatkowska U; Okulczyk B; Kedra B; Łaszewicz W; Dabrowski A; Szmitkowski M
Clin Chim Acta; 2007 May; 380(1-2):208-12. PubMed ID: 17368603
[TBL] [Abstract][Full Text] [Related]
26. Combination of serum carcino-embryonic antigen and C-reactive protein--a useful test in preoperative staging of colorectal cancer.
Stamatiadis AP; Manouras AJ; Triantos GN; Katergiannakis VA; Apostolidis NS
Eur J Surg Oncol; 1992 Feb; 18(1):41-3. PubMed ID: 1737592
[TBL] [Abstract][Full Text] [Related]
27. [Acute phase reactants--haptoglobin, transferrin, alpha 1-antitrypsin--in colorectal cancer].
Codina Cazador A; Salvá Lacombe JA; Fernández-Llamazares Rodríguez J; Tuca Rodríguez F; Durán Porta JA; Baeza Salcedo J
Rev Esp Enferm Apar Dig; 1988 Aug; 74(2):109-13. PubMed ID: 2460905
[No Abstract] [Full Text] [Related]
28. [Value of serologic markers in the management of colorectal cancer].
Wainstein RC; Milano MC
Acta Gastroenterol Latinoam; 1995; 25(5):309-10. PubMed ID: 8733259
[No Abstract] [Full Text] [Related]
29. How useful is carcinoembryonic antigen in detecting colorectal malignancy?
Buhagiar M; Ellul P
Eur J Intern Med; 2013 Jul; 24(5):480-1. PubMed ID: 23352154
[No Abstract] [Full Text] [Related]
30. Serum levels of acute phase proteins in patients with nonalcoholic steatohepatitis.
Koruk M; Tayşi S; Savaş MC; Yilmaz O; Akçay F; Karakök M
Turk J Gastroenterol; 2003 Mar; 14(1):12-7. PubMed ID: 14593532
[TBL] [Abstract][Full Text] [Related]
31. Carcinoembryonic antigen monitoring for early detection of asymptomatic incurable metastatic colorectal cancer.
Rother M
J Clin Oncol; 2007 Apr; 25(10):1293-4; author reply 1294. PubMed ID: 17401025
[No Abstract] [Full Text] [Related]
32. [Significance of CEA and CA 19-9 for after care of curatively resected colorectal cancers].
Stapel A; Franke U; Putzki H
Zentralbl Chir; 1992; 117(2):77-80. PubMed ID: 1315472
[TBL] [Abstract][Full Text] [Related]
33. [Usefulness of evaluation of carcinoembryonic antigen (CEA) and soluble fragments of cytokeratin 18-th (TPS) in postoperative monitoring of patients with colorectal cancer].
Sandelewski A; Kokocińska D; Partyka R; Kocot J; Starzewski J; Chanek I; Jałowiecki P
Pol Merkur Lekarski; 2005 Jun; 18(108):647-50. PubMed ID: 16124375
[TBL] [Abstract][Full Text] [Related]
34. CEA, TPS, CA 19-9 and CA 72-4 and the fecal occult blood test in the preoperative diagnosis and follow-up after resective surgery of colorectal cancer.
Griesenberg D; Nürnberg R; Bahlo M; Klapdor R
Anticancer Res; 1999; 19(4A):2443-50. PubMed ID: 10470173
[TBL] [Abstract][Full Text] [Related]
35. Is C-reactive protein a prognostic factor of colorectal cancer?
Shiu YC; Lin JK; Huang CJ; Jiang JK; Wang LW; Huang HC; Yang SH
Dis Colon Rectum; 2008 Apr; 51(4):443-9. PubMed ID: 18172726
[TBL] [Abstract][Full Text] [Related]
36. Serum and acute phase protein modulation of the effector phase of lymphokine-activated killer cells.
Clayman GL; Taylor DL; Liu FJ; Lavedan P; Savage HE; Schantz SP
Laryngoscope; 1993 Mar; 103(3):299-307. PubMed ID: 7680086
[TBL] [Abstract][Full Text] [Related]
37. [Clinical significance of plasma fibrinogen level in patients with colorectal cancer].
Wang Q; Xie R; Zhang QY
Zhonghua Zhong Liu Za Zhi; 2005 Sep; 27(9):544-6. PubMed ID: 16438853
[TBL] [Abstract][Full Text] [Related]
38. [Serum markers in breast cancer and colorectal cancer (1997)].
Bellet D; Mlika-Cabanne N; Bedenne L; Brun B; Demeaux JL; Legrand JL; Lorimier G; Mignotte H; Ollivier JM; Piperno-Neumann S; Rinaldi Y; Rousset H; Rymer JC; Laversin S
Gynecol Obstet Fertil; 2001 Jan; 29(1):62-3. PubMed ID: 11217195
[No Abstract] [Full Text] [Related]
39. Serum tumor markers in colorectal cancer staging, grading, and follow-up.
Plebani M; De Paoli M; Basso D; Roveroni G; Giacomini A; Galeotti F; Corsini A
J Surg Oncol; 1996 Aug; 62(4):239-44. PubMed ID: 8691835
[TBL] [Abstract][Full Text] [Related]
40. Serum proteolytic activities and antiproteases in human colorectal carcinoma.
Amiguet JA; Jiménez J; Monreal JI; Hernández MJ; López-Vivanco G; Vidán JR; Conchillo F; Liso P
J Physiol Biochem; 1998 Mar; 54(1):9-13. PubMed ID: 9732103
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
